Kobo Biotech Financials

BSE: 531541

₹5.10

₹-0.09 (-1.73%)

As on 04-Sep-2026IST

Market cap

₹12 Cr

Revenue (TTM)

₹-- Cr

P/E Ratio

--

P/B Ratio

-0.1

Div. Yield

0 %

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	--	--	--	--	--	--
Total Income	0.08	0.02	0.02	133.38	0.04	1.95
Total Expenditure	1.23	0.87	1.50	143.87	2.79	2.61
EBITDA	-1.23	-0.87	-1.50	-143.87	-2.79	-2.61
Depreciation	4.07	4.07	4.07	4.61	5.64	5.88
EBIT	-5.31	-4.94	-5.57	-148.47	-8.43	-8.49
Interest	0.00	0.00	0.00	0.13	10.84	14.47
Other Income	0.08	0.02	0.02	133.38	0.04	1.95
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-5.23	-4.93	-5.55	-15.23	-19.23	-21.01
Provision for Tax	--	--	--	--	--	--
Profit after Tax	-5.23	-4.93	-5.55	-15.23	-19.23	-21.01

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	-138.14	-132.91	-127.98	-122.43	-107.20	-87.97
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	36.48	36.48	37.43	38.30	38.63	40.03
Current Liabilities	173.25	167.82	165.88	163.31	299.16	284.27
Total Liabilities	71.59	71.39	75.33	79.19	230.59	236.33

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	29.44	33.52	37.59	41.66	71.36	76.99
Current Assets	42.15	37.88	37.74	37.53	159.23	159.34
Total Assets	71.59	71.39	75.33	79.19	230.59	236.33
Total Debt*	139.69	139.69	139.84	140.72	260.53	250.77
Net Current Assets	-131.10	-129.94	-128.14	-125.79	-139.93	-124.93
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	4.18	2.56	0.87	93.76	2.51	14.48
Cash Flow from Investing Activities	--	4.07	--	25.09	--	0.00
Cash from Financing Activities	--	-1.02	-0.87	-120.28	-1.08	-14.47
Net Cash Inflow / Outflow	4.18	5.61	0.00	-1.43	1.43	0.00

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	-2.20	-2.07	-2.33	-6.39	-8.07	-8.82
Cash EPS (₹)	-0.49	-0.36	-0.62	-4.46	-5.71	-6.35
Adjusted Book Value (₹)	-57.98	-55.79	-53.72	-51.39	-45.00	-36.92
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	1.75	1.07	0.37	39.35	1.05	6.08
Free Cash Flow per Share (₹)	1.75	1.07	0.37	39.30	-3.50	0.00

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	-125.54	-52.88	-36.84	-17.59	-5.31	-3.93
ROE (%)	--	--	--	--	--	--
ROA (%)	-7.32	-6.72	-7.19	-9.83	-8.24	-8.83
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	-6,881.32	-32,426.32	-36,535.53	-11.42	-53,569.08	-1,074.82
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-7.32	11.22	96.25	-1,661.97	0.70	7.15
Net Profit Growth (%)	-6.11	11.25	63.53	20.83	8.45	14.12
EPS Growth (%)	-6.11	11.24	63.53	20.83	8.45	14.12
Book Value Growth (%)	-3.93	-3.85	-4.54	-14.20	-21.86	-31.37

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	-1.44	-1.84	-0.82	--	--	--
Price / Book Value	-0.05	-0.07	-0.04	-0.11	-0.16	-0.08
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-123.32	-173.29	-97.37	-14.66	-100.45	-394.17
Close Price (₹)	3.15	3.80	1.90	5.50	7.40	2.89
High Price (₹)	5.11	6.01	6.73	11.88	10.41	5.77
Low Price (₹)	2.51	1.86	1.86	3.80	1.85	1.19
Market Cap (₹ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	-1.01	-1.05	-1.09	-1.15	-2.43	-2.85
Short term debt to equity ratio	-0.43	-0.45	-0.47	-0.49	-1.63	-1.86
Current Ratio	0.24	0.23	0.23	0.23	0.53	0.56
Quick Ratio	0.14	0.12	0.12	0.12	0.35	0.37
Interest Coverage	-52,297.00	-49,287.00	-27,766.00	-111.95	-0.77	-0.45

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--